Rugo, H. S., Dieras, V., Cortes, J., Patt, D., Wildiers, H., O’Shaughnessy, J., . . . Tolaney, S. M. (2020). Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1. Breast Cancer Res Treat.
Citação norma ChicagoRugo, Hope S., et al. "Real-world Survival Outcomes of Heavily Pretreated Patients With Refractory HR+, HER2−metastatic Breast Cancer Receiving Single-agent Chemotherapy—a Comparison With MONARCH 1." Breast Cancer Res Treat 2020.
Citação norma MLARugo, Hope S., et al. "Real-world Survival Outcomes of Heavily Pretreated Patients With Refractory HR+, HER2−metastatic Breast Cancer Receiving Single-agent Chemotherapy—a Comparison With MONARCH 1." Breast Cancer Res Treat 2020.